is tirzepatide zepbound or mounjaro FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

These are very similar to what patients experience on semaglutide or tirzepatide

Significant weight loss potential Clinical studies show that semaglutide produces substantial results

A total of 34% of recipients of a 2 mg dose had gastrointestinal symptoms compared with 30.8% of those receiving a 1 mg dose

We have shown that more mechanisms produce greater weight loss. Both Drugs Led to Significant Weight Loss Almost one-third of participants on Zepbound lost at least 25 percent of their body weight, compared with 16 percent for Wegovy

Cardoso BR, Duarte GBS, Reis BZ, Cozzolino SMF

However, it remains unsuitable for individuals with specific medical histories, such as medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2